Definition and Overview
Sepsis in children is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. Septic shock is a subset of sepsis with cardiovascular dysfunction persisting despite adequate fluid resuscitation, characterised by the need for vasoactive support and/or evidence of tissue hypoperfusion (elevated lactate, altered mental state, prolonged capillary refill).
Paediatric sepsis is distinct from adult sepsis in several respects:
- Children mount a more vigorous inflammatory response and may compensate haemodynamically until late decompensation
- Hypotension is a late and pre-terminal sign in children; the absence of hypotension does not exclude shock
- Age-specific vital sign thresholds must be used (see table below)
- The commonest phenotype of paediatric septic shock is cold shock (high SVR, low CO), in contrast to adults who more commonly present with warm vasodilatory shock
Epidemiology:
- Incidence approximately 2-4% of PICU admissions in Australia and New Zealand; mortality 4-10% in high-income settings, higher in resource-limited environments
- Leading organisms vary by age: Group B Streptococcus and gram-negatives in neonates; Streptococcus pneumoniae, Neisseria meningitidis in infants and toddlers; Staphylococcal and gram-negative enteric pathogens across all ages
Age-Specific Physiological Thresholds
| Age Group | HR Tachycardia (bpm) | Hypotension (systolic mmHg) | Normal SBP lower limit |
|---|---|---|---|
| 0-1 month | >180 | <60 | 60 |
| 1-12 months | >180 | <70 | 70 |
| 1-5 years | >140 | <74 | 74 |
| 6-12 years | >130 | <83 | 83 |
| >12 years | >110 | <90 | 90 |
A practical bedside approximation for the lower limit of normal systolic BP in children aged 1-10 years: $\text{SBP}_{\min} = 70 + (2 \times \text{age in years})\,\text{mmHg}$.
Pathophysiology
Initial Inflammatory Cascade
Pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) activate pattern recognition receptors (toll-like receptors), triggering release of pro-inflammatory cytokines (TNF-$\alpha$, IL-1, IL-6). This drives:
- Endothelial activation, increased vascular permeability, and third-space fluid shifts
- Coagulopathy (consumptive coagulopathy, DIC)
- Mitochondrial dysfunction and impaired oxygen utilisation
Haemodynamic Phenotypes in Children
$$\text{DO}_2 = \text{CO} \times \text{CaO}_2 = (\text{HR} \times \text{SV}) \times (1.34 \times \text{Hb} \times \text{SpO}_2 + 0.003 \times \text{PaO}_2)$$
- Cold shock (most common in children): elevated SVR, reduced cardiac output, poor peripheral perfusion, mottled cool extremities, prolonged CRT $>2$ seconds. Adrenaline-responsive.
- Warm shock: reduced SVR, bounding pulses, flash CRT; more common in older children and adolescents, and in gram-negative/endotoxin-mediated sepsis. Noradrenaline-responsive.
- Progression to refractory shock involves absolute adrenal insufficiency, myocardial dysfunction, and multi-organ failure
Clinical Recognition
Red Flag Features
- Altered mental state, inconsolable irritability, or decreased responsiveness
- Prolonged capillary refill time $>2$ seconds or flash CRT $<1$ second
- Mottled skin, pallor, or peripheral cyanosis
- Tachycardia out of proportion to fever
- Oliguria (urine output $<1\,\text{mL/kg/hr}$ in children, $<0.5\,\text{mL/kg/hr}$ in adolescents)
- Non-blanching petechial or purpuric rash (meningococcaemia until proven otherwise)
- New hepatomegaly (indicator of venous congestion and right heart dysfunction)
PICU Triage: Recognising Fluid-Refractory Shock
Fluid-refractory septic shock is defined as persistent signs of shock after $\geq 40\,\text{mL/kg}$ of isotonic crystalloid within the first hour. These children require urgent vasoactive support, ICU admission, and reassessment of diagnosis.
Investigations
| Domain | Investigation | Rationale |
|---|---|---|
| Microbiology | Blood cultures $\times$2 (peripheral + central), urine MC&S, wound/LP as indicated | Before antibiotics if $<$45 min delay; do not delay antibiotics for cultures |
| Haematology | FBC, coagulation panel (PT, APTT, fibrinogen, D-dimer) | Leucocytosis/leucopenia, thrombocytopenia, DIC screen |
| Biochemistry | UEC, LFTs, LDH, CRP, procalcitonin, glucose, ionised calcium | Organ dysfunction, metabolic derangement |
| Gas/lactate | ABG or VBG with lactate | Lactate $>2\,\text{mmol/L}$ indicates tissue hypoperfusion; reassay if $>4$ |
| Imaging | CXR, bedside POCUS (cardiac function, IVC, effusions) | Source identification, cardiac phenotyping |
| Other | $\beta$-D-glucan, galactomannan if immunocompromised | Fungal screen |
Lactate is a key marker: elevated lactate in the setting of shock mandates early aggressive resuscitation even if BP is maintained. Serial lactate guides response to therapy.
Management
Step 1: Simultaneous Resuscitation and Recognition (0-15 minutes)
- High-flow oxygen via non-rebreather mask; prepare for early intubation if work of breathing is high or GCS declining
- Establish two large-bore IV cannulae or intraosseous (IO) access; IO is first-line if IV access fails after 90 seconds
- Blood cultures (do not delay antibiotics $>1$ hour)
- Point-of-care glucose, lactate, gas
- Activate sepsis pathway and notify PICU/retrieval team early
Step 2: Fluid Resuscitation (First Hour)
- Initial bolus: $10\,\text{mL/kg}$ isotonic crystalloid (0.9% NaCl or Hartmann's/PlasmaLyte) over 5-10 minutes, with reassessment after each bolus
- Repeat boluses of $10\,\text{mL/kg}$ to a maximum of $40\,\text{mL/kg}$ in the first hour, titrating to clinical response (CRT, HR, mental state, urine output)
- After $20\,\text{mL/kg}$: reassess for signs of fluid overload (new hepatomegaly, increased work of breathing, worsening oxygenation); if present, transition earlier to vasoactive support
- Neonates and children with known or suspected cardiac disease: use $5\,\text{mL/kg}$ boluses with very careful reassessment; avoid large volume resuscitation without senior review
Key divergence from adult practice: The FEAST trial demonstrated harm from liberal bolus therapy in resource-limited settings without ICU backup. In Australian and New Zealand PICUs, bolus resuscitation with close monitoring and early escalation to vasoactives remains standard; routine restriction of all fluid boluses is not supported in the well-resourced PICU environment, but avoidance of fluid overload $>10$% body weight is a clear goal.
Step 3: Antimicrobials (within 1 hour of recognition, ideally $<$30 min for shock)
- Empiric broad-spectrum antibiotics should be given within 60 minutes of recognition (within 30 minutes for septic shock)
- Default regimen in most Australian and New Zealand PICUs: Piperacillin-tazobactam $100\,\text{mg/kg}$ (piperacillin component) IV 6-hourly (max $4\,\text{g}$ per dose) plus Gentamicin $7\,\text{mg/kg}$ IV daily (neonates: age-adjusted dosing, consult pharmacy)
- Add Vancomycin $15\,\text{mg/kg}$ IV 6-hourly (max $750\,\text{mg}$ per dose) if: central line in situ, gram-positive source suspected, MRSA risk, or neutropenic patient
- Add Aciclovir $10-15\,\text{mg/kg}$ IV 8-hourly if HSV encephalitis or neonatal HSV is possible
- Antifungal (Caspofungin $70\,\text{mg/m}^2$ loading, then $50\,\text{mg/m}^2$ daily) in immunocompromised or prolonged broad-spectrum antibiotic exposure
- De-escalate at 48-72 hours when cultures and sensitivities are available
Step 4: Vasoactive Support (Fluid-Refractory Shock)
Initiate vasoactives if shock persists after $\geq 20\,\text{mL/kg}$ OR signs of fluid overload appear. Do not wait for $40\,\text{mL/kg}$ if clinical deterioration is evident.
| Shock Phenotype | First-Line Agent | Dose Range | Rationale |
|---|---|---|---|
| Cold shock | Adrenaline | $0.05-1\,\mu\text{g/kg/min}$ IV | Increases CO and HR; inotrope + vasopressor |
| Warm shock | Noradrenaline | $0.05-1\,\mu\text{g/kg/min}$ IV | Increases SVR; minimal chronotropy |
| Distributive/refractory | Add Vasopressin | $0.0003-0.002\,\text{U/kg/min}$ IV | Catecholamine-sparing; V1 vasoconstriction |
| Low CO/myocardial dysfunction | Add Dobutamine or Milrinone | $5-20\,\mu\text{g/kg/min}$; $0.25-0.75\,\mu\text{g/kg/min}$ | Augments contractility; milrinone also reduces afterload |
- Peripheral vasoactives are acceptable for short-term stabilisation (30-60 min) while central access is established
- Central venous access should be obtained early for reliable drug delivery and CVP/ScvO$_2$ monitoring
- ScvO$_2$ target $\geq 70$%: if $<70$%$ despite fluid and vasopressor optimisation, consider transfusion to Hb $\geq 80\,\text{g/L}$ or addition of inotrope
Step 5: Source Control
- Drain any accessible collection (abscess, empyema, infected effusion) within 6-12 hours of identification
- Remove infected intravascular devices (central lines, PICC lines) where source of bacteraemia; balance against need for access
- Surgical consultation early for necrotising fasciitis, intestinal perforation, or undrained pus
Step 6: Corticosteroids (Catecholamine-Resistant Shock)
- Indicated in catecholamine-resistant septic shock and when adrenal insufficiency is suspected (prolonged steroid use, adrenal haemorrhage, purpuric rash of meningococcaemia)
- Hydrocortisone $1-2\,\text{mg/kg/dose}$ IV 6-hourly (max $50\,\text{mg}$ per dose); some units use a continuous infusion
- Cosyntropin stimulation testing is not required before commencing in the acute setting
Monitoring Targets During Resuscitation
| Parameter | Target |
|---|---|
| CRT | $\leq 2$ seconds |
| HR | Returning to age-appropriate normal range |
| MAP | $\geq 5^{th}$ percentile for age (use age-formula) |
| Urine output | $\geq 1\,\text{mL/kg/hr}$ |
| Lactate | Clearance $\geq 10$% per hour; target $<2\,\text{mmol/L}$ |
| ScvO$_2$ | $\geq 70$% |
| Glucose | $4-10\,\text{mmol/L}$ |
| Ionised Ca$^{2+}$ | $\geq 1.1\,\text{mmol/L}$ (correct hypocalcaemia; common in sepsis) |
Special Considerations
Neonatal Sepsis at the PICU Interface
- Group B Streptococcus, Listeria, and gram-negative enteric organisms dominate early-onset; coagulase-negative staphylococci and Candida in late-onset NICU sepsis
- Empiric regimen: Benzylpenicillin $60\,\text{mg/kg}$ IV 12-hourly (term) plus Gentamicin $5\,\text{mg/kg}$ IV 36-hourly (term neonate); adjust for gestation and age
- Neonates may present with temperature instability, poor feeding, apnoea, or metabolic acidosis rather than classic sepsis signs
- Avoid prolonged fasting; early dextrose-containing fluids to prevent hypoglycaemia
Meningococcaemia
- Ceftriaxone $100\,\text{mg/kg}$ IV (max $4\,\text{g}$) stat as soon as blood cultures drawn; do not delay for LP
- Anticipate DIC, adrenal haemorrhage (Waterhouse-Friderichsen), and rapid progression to refractory shock
- Prophylaxis for close contacts: notify public health; ciprofloxacin or rifampicin per weight-based dosing
Immunocompromised Host
- Fever in a neutropenic child (ANC $<0.5 \times 10^9/\text{L}$) is a medical emergency
- Empiric coverage must include gram-negative cover including Pseudomonas: Piperacillin-tazobactam or Meropenem $20\,\text{mg/kg}$ IV 8-hourly
- Lower threshold for antifungals, antivirals; consult haematology/oncology early
Retrieval and Transport
- Stabilise before transfer: establish airway if required, secure vascular access, commence vasoactives via peripheral line if needed
- Communicate ISBAR-structured handover; document resuscitation volumes, antibiotics given with times and doses
- Anticipate deterioration in transport: ensure vasoactive infusions are reliable, have adrenaline drawn up for arrest ($10\,\mu\text{g/kg}$ IV/IO)
Complications
- Fluid overload: cumulative fluid balance $>10$% body weight is independently associated with worse outcomes; use diuretics or early CRRT if oliguric and fluid-overloaded once haemodynamically stable
- PARDS: lung-protective ventilation if intubated ($V_T$ $5-7\,\text{mL/kg}$ IBW, PEEP titration, $\text{FiO}_2$ minimised)
- AKI: monitor creatinine, urine output, electrolytes; avoid nephrotoxic drug accumulation (aminoglycosides: single daily dosing, levels)
- DIC: FFP $10\,\text{mL/kg}$ IV, cryoprecipitate $5\,\text{mL/kg}$ IV, platelets $10\,\text{mL/kg}$ IV as guided by coagulation and bleeding
- Hypoglycaemia: common in infants; check glucose every 1-2 hours during acute resuscitation; treat with $2\,\text{mL/kg}$ of 10% dextrose IV
- Hypocalcaemia: ionised calcium $<1.1\,\text{mmol/L}$ impairs cardiac contractility; replace with Calcium gluconate $0.1\,\text{mmol/kg}$ IV slowly
PICU Exam Framing: Viva Anchors
- Always state age-specific thresholds when asked to recognise shock; hypotension is a late sign in children
- Fluid bolus 10 mL/kg with reassessment is the paediatric standard; not 30 mL/kg as in adult Surviving Sepsis; distinguish your practice
- Cold shock = adrenaline first; warm shock = noradrenaline first; this is a high-yield differentiator
- When asked about corticosteroids: reserve for catecholamine-resistant shock; hydrocortisone at stress dosing
- Antibiotics within 60 minutes, ideally within 30 minutes for established shock: state the time target explicitly in viva
- Document and communicate: fluids given, antibiotics with times, vasoactive doses, and response are all essential for safe retrieval handover and PICU admission